CIAM
INO icon

Caitong International Asset Management’s Inovio Pharmaceuticals INO Stock Holding History

Caitong International Asset Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
10,022
+10,006
+62,538% +$11.9K ﹤0.01% 1139
2026
Q1 		$28 Sell
16
-48,932
-100% -$80.5K ﹤0.01% 2053
2025
Q4 		$85.2K Buy
48,948
+46,536
+1,929% +$103K 0.02% 497
2025
Q3 		$5.64K Sell
2,412
-140
-5% -$268 ﹤0.01% 1197
2025
Q2 		$5.19K Buy
2,552
+1,860
+269% +$3.56K ﹤0.01% 998
2025
Q1 		$1.13K Buy
+692
New +$1.39K ﹤0.01% 1537

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Caitong International Asset Management's INO Position: Q2 2026 in Review

Caitong International Asset Management increased its Inovio Pharmaceuticals (INO) stake by 62,538% in Q2 2026, buying an estimated $11.9K and bringing the position to 10,022 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

Caitong International Asset Management first reported a position in INO in Q1 2025 and has held it in 6 quarters since. The position peaked at $85.2K in Q4 2025. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Caitong International Asset Management held 10,022 shares of Inovio Pharmaceuticals worth $11K as of Q2 2026.
  • Caitong International Asset Management bought 10,006 Inovio Pharmaceuticals shares in Q2 2026, an estimated $11.9K.
  • Inovio Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1139 holding.
  • Caitong International Asset Management first reported a position in Inovio Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Caitong International Asset Management's Inovio Pharmaceuticals position peaked at $85.2K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.